MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $20,972,000 | +258.9% | 347,789 | +173.6% | 0.07% | +266.7% |
| Q1 2016 | $5,844,000 | +55.6% | 127,108 | +63.6% | 0.02% | +63.6% |
| Q4 2015 | $3,755,000 | +14.0% | 77,673 | +0.2% | 0.01% | +10.0% |
| Q3 2015 | $3,293,000 | -85.7% | 77,488 | -61.5% | 0.01% | -83.6% |
| Q2 2015 | $22,981,000 | -38.3% | 201,232 | -30.2% | 0.06% | -35.1% |
| Q1 2015 | $37,230,000 | -9.2% | 288,450 | -29.9% | 0.09% | -9.6% |
| Q4 2014 | $40,995,000 | -34.6% | 411,559 | -35.1% | 0.10% | -33.8% |
| Q3 2014 | $62,663,000 | -69.4% | 633,795 | -76.1% | 0.16% | -32.9% |
| Q2 2014 | $204,874,000 | +75.1% | 2,657,376 | +46.2% | 0.23% | -12.0% |
| Q1 2014 | $116,998,000 | +984.6% | 1,817,579 | +975.3% | 0.27% | +1008.3% |
| Q4 2013 | $10,787,000 | -67.0% | 169,026 | -69.0% | 0.02% | -68.0% |
| Q3 2013 | $32,664,000 | +702.8% | 544,946 | +558.9% | 0.08% | +733.3% |
| Q2 2013 | $4,069,000 | – | 82,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |